Clinical Trial Update: Urokinase Therapy in Patients With Diabetic Foot Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating urokinase therapy in patients with diabetic foot syndrome has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Syndrome
• Ischemia
• Peripheral Artery Disease

Drugs mentioned

• Urokinase (urokinase)

Snippet

Sponsor: medac GmbH | Conditions: Diabetic Foot, Arterial Occlusive Disease | Phase 3 | Status: TERMINATED